title: Combination of immunosuppressive drugs for organ transplantation.
abstract: Several novel immunosuppressive agents have been developed in recent years. They exhibited not only remarkable immunosuppressive potency but also side effects. They are still short of the final goal in terms of immunosuppression for organ transplantation. Combination treatment is more effective and safer to use, and it will prevail in the future.
authors.affiliation: Department of Surgery, School of Medicine, Chiba University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ochiai
authors.forename: Y
authors.initials: Y
authors.lastname: Gunji
authors.forename: M
authors.initials: M
authors.lastname: Nagata
authors.forename: K
authors.initials: K
authors.lastname: Isono
mesh_terms: D000681:Amylases / Q000097:blood; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000502:physiology; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D011090:Polyenes / Q000008:administration & dosage / Q000009:adverse effects; D020123:Sirolimus; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects; D014183:Transplantation, Heterologous; D014657:Vasculitis / Q000139:chemically induced
chemical_list: D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D000681:Amylases; D020123:Sirolimus; D016559:Tacrolimus